Dr. Reddy’s Laboratories launches Regadenoson Injection 0.4mg/5mL in US market, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The injection is the generic therapeutic equivalent of the US Food and Drug Administration (US FDA)-approved Lexiscan (Regadenoson) injection. To test the heart for coronary artery disease, the injection is utilised., The injection is the generic therapeutic equivalent of the US Food and Drug Administration (US FDA)-approved Lexiscan (Regadenoson) injection. To test the heart for coronary artery disease, the injection is utilised., , Read More